DB, there is no milestone bonus or anything like that on submitting BLA, its simply a huge advancement toward final approval of Leronlimab for HIV. Its been a long grueling process to complete the rolling review BLA application and to finally put the BLA debate to rest would be a welcome catalyst for the investment community.